Pharma companies and CROs are recognizing the need for focused electronic feasibility solutions to resolve challenges with processes managed in Excel trackers.
Overcoming the many known barriers to adopting and implementing an RBM program.
Learn six strategies for success when developing your companion diagnostic.
In a recent New York Times article, Paula Span raises the concern that elderly subjects are frequently omitted from clinical trials. Consequently, physicians know very little about how a given treatment may affect their older patients. Is a medication effective for the elderly? Is it safe? Without data, how is a physician to know?
There is a significant need to collect Real World Evidence (RWE) to demonstrate the benefit of these drugs in clinical practice which can then be used as the wrap around to demonstrate true clinical benefit and address all stakeholder needs.
Sponsors who partner with a global central laboratory should expect optimized outcomes resulting from a depth of immuno-oncology and technological expertise and harmonized processes.
Learn 6 critical ways to keep track of the flu to optimize your seasonal flu vaccine development clinical trials.
Successful clinical trial recruitment requires a thorough understanding of the target patient profile, and a key factor within this profile is patient motivation. What drives a patient to consider, then subsequently inquire, prescreen, and finally consent and participate in a trial? While these motivations will vary by previous research experience, indication or condition, study type, patient demographics, and other elements, common themes often emerge when one speaks to patients directly about their reasoning.
Learn more about different genomic assays that can be used during clinical development and which ones are right for your study.
A critical component in the fight against cancer and optimizing treatment outcomes for patients.
|
|
|
|
|
|
|
|
|